Northeast Investment Management Sells 2,281 Shares of Danaher Co. (NYSE:DHR)

Northeast Investment Management lessened its holdings in shares of Danaher Co. (NYSE:DHR) by 1.3% during the fourth quarter, Holdings Channel reports. The firm owned 175,215 shares of the conglomerate’s stock after selling 2,281 shares during the quarter. Danaher makes up about 1.8% of Northeast Investment Management’s investment portfolio, making the stock its 18th biggest position. Northeast Investment Management’s holdings in Danaher were worth $40,221,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in DHR. Entropy Technologies LP boosted its position in shares of Danaher by 126.4% during the fourth quarter. Entropy Technologies LP now owns 54,567 shares of the conglomerate’s stock valued at $12,526,000 after purchasing an additional 30,464 shares in the last quarter. Empowered Funds LLC boosted its stake in Danaher by 9.8% in the 4th quarter. Empowered Funds LLC now owns 17,420 shares of the conglomerate’s stock worth $3,999,000 after purchasing an additional 1,550 shares in the last quarter. Wilmington Savings Fund Society FSB increased its stake in Danaher by 6.5% during the 4th quarter. Wilmington Savings Fund Society FSB now owns 38,422 shares of the conglomerate’s stock valued at $8,820,000 after purchasing an additional 2,347 shares in the last quarter. Kingsview Wealth Management LLC lifted its stake in shares of Danaher by 7.1% in the fourth quarter. Kingsview Wealth Management LLC now owns 40,795 shares of the conglomerate’s stock worth $9,364,000 after buying an additional 2,690 shares in the last quarter. Finally, MWA Asset Management lifted its position in Danaher by 13.7% in the 4th quarter. MWA Asset Management now owns 1,432 shares of the conglomerate’s stock valued at $329,000 after acquiring an additional 172 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on DHR shares. Stephens reissued an “overweight” rating and set a $315.00 price objective on shares of Danaher in a report on Wednesday, October 23rd. Jefferies Financial Group decreased their price target on shares of Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a research report on Wednesday, January 29th. Robert W. Baird decreased their target price on Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Wells Fargo & Company decreased their target price on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research note on Thursday, January 30th. Finally, Barclays decreased their price objective on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. Seven research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average price target of $278.00.

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 11.10% of the company’s stock.

Danaher Stock Performance

NYSE:DHR opened at $206.92 on Friday. The company’s 50-day moving average is $232.72 and its two-hundred day moving average is $251.79. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The firm has a market capitalization of $149.45 billion, a price-to-earnings ratio of 39.19, a PEG ratio of 2.68 and a beta of 0.83. Danaher Co. has a 1-year low of $205.79 and a 1-year high of $281.70.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period last year, the business earned $2.09 EPS. Analysts forecast that Danaher Co. will post 7.67 EPS for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.52%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s payout ratio is currently 20.45%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.